Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 2004

View Archived Issues

Highlights from the 12th Annual Biopartnering Europe conference now available on LifeSciChannel.com

New peptides with thrombin-inhibitory activity designed by Canadian scientists

Several series of PPAR agonists presented by Aventis researchers

Emerging companies showcased at the 12th Annual BioPartnering Europe conference: Alexza

Karo Bio presents new peptides modulating androgen receptors

Emerging companies showcased at the 12th Annual BioPartnering Europe conference: Allon Therapeutics

Novel IBAT inhibitors in early development at AstraZeneca

New antibacterial oxazolidinones patented by AstraZeneca

New mGluR5 antagonists prepared and tested at Addex

ARS scientists develop new prostanoid agonists for female infertility, asthma, etc.

Enrollment completed in phase II actinic keratosis study of Polyphenon E

Aricept ODT receives FDA approval

Two-year research program into macrolide development for TB

Positive opinion for Fendrix in Europe

European CHMP hands down positive opinion for Quintanrix

European Committee adopts extension of indication for Vfend

Peplin completes phase I study of PEP-005 Topical

Japanese approval for PegIntron in combination with Rebetol

New HCV studies unveiled for PegIntron in difficult-to-treat populations

Approvable letter for Thalomid sNDA for multiple myeloma

Tiagabine shows promise in anxiety and PTSD

Preclinical evidence for the antiapoptotic effects of tempol in the brain

Therapeutic benefits of lasofoxifene in menopausal vaginal atrophy

Synthesis of highly potent peptidomimetic beta-secretase inhibitors

Zonisamide reported effective and safe in children with epilepsy

Trypanocidal agent targets mitochondrial function in yeast

Glycine may represent a novel eradication therapy against drug-resistant H. pylori

Promising class of antibiotic agents against multiple antibiotic-resistant Gram-positive bacteria

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...